vs
Orthofix Medical Inc.（OFIX）与Childrens Place, Inc.（PLCE）财务数据对比。点击上方公司名可切换其他公司
Childrens Place, Inc.的季度营收约是Orthofix Medical Inc.的1.5倍（$339.5M vs $219.9M），Orthofix Medical Inc.净利率更高（-1.0% vs -1.3%，领先0.3%），Orthofix Medical Inc.同比增速更快（2.0% vs -13.0%），Orthofix Medical Inc.自由现金流更多（$16.8M vs $-3.4M），过去两年Orthofix Medical Inc.的营收复合增速更高（8.0% vs -13.6%）
Orthofix医疗是全球知名骨科医疗器械企业，专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品，服务全球多地的骨科医师与医疗机构，致力于提升肌肉骨骼疾病患者的诊疗效果。
Children’s Place是专业儿童服饰零售商，产品主要以旗下自有品牌发售，涵盖Gymboree、Sugar & Jade、PJ Place、Crazy 8等。目前该品牌在美国、加拿大、波多黎各共开设约525家门店，同时通过两个线上渠道以及15个国家的5家加盟合作伙伴开展销售，产品涵盖上衣、裙装、鞋履、裤装、睡衣、背包等全品类儿童服饰配件。
OFIX vs PLCE — 直观对比
营收规模更大
PLCE
是对方的1.5倍
$219.9M
营收增速更快
OFIX
高出15.0%
-13.0%
净利率更高
OFIX
高出0.3%
-1.3%
自由现金流更多
OFIX
多$20.2M
$-3.4M
两年增速更快
OFIX
近两年复合增速
-13.6%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $219.9M | $339.5M |
| 净利润 | $-2.2M | $-4.3M |
| 毛利率 | 71.1% | 33.1% |
| 营业利润率 | 0.2% | 1.1% |
| 净利率 | -1.0% | -1.3% |
| 营收同比 | 2.0% | -13.0% |
| 净利润同比 | 92.4% | -121.5% |
| 每股收益（稀释后） | $-0.05 | $-0.19 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收OFIXPLCE
| Q4 25 | $219.9M | $339.5M | ||
| Q3 25 | $205.6M | $298.0M | ||
| Q2 25 | $203.1M | $242.1M | ||
| Q1 25 | $193.6M | $408.6M | ||
| Q4 24 | $215.7M | $390.2M | ||
| Q3 24 | $196.6M | $319.7M | ||
| Q2 24 | $198.6M | $267.9M | ||
| Q1 24 | $188.6M | $455.0M |
净利润OFIXPLCE
| Q4 25 | $-2.2M | $-4.3M | ||
| Q3 25 | $-22.8M | $-5.4M | ||
| Q2 25 | $-14.1M | $-34.0M | ||
| Q1 25 | $-53.1M | $-8.0M | ||
| Q4 24 | $-29.1M | $20.1M | ||
| Q3 24 | $-27.4M | $-32.1M | ||
| Q2 24 | $-33.4M | $-37.8M | ||
| Q1 24 | $-36.0M | $-128.8M |
毛利率OFIXPLCE
| Q4 25 | 71.1% | 33.1% | ||
| Q3 25 | 72.2% | 34.0% | ||
| Q2 25 | 68.7% | 29.2% | ||
| Q1 25 | 62.8% | 28.5% | ||
| Q4 24 | 69.0% | 35.5% | ||
| Q3 24 | 68.7% | 35.0% | ||
| Q2 24 | 67.8% | 34.6% | ||
| Q1 24 | 67.5% | 21.8% |
营业利润率OFIXPLCE
| Q4 25 | 0.2% | 1.1% | ||
| Q3 25 | -8.3% | 1.4% | ||
| Q2 25 | -7.9% | -10.0% | ||
| Q1 25 | -25.2% | 1.7% | ||
| Q4 24 | -5.3% | 7.5% | ||
| Q3 24 | -9.6% | -6.8% | ||
| Q2 24 | -12.5% | -10.4% | ||
| Q1 24 | -15.6% | -13.6% |
净利率OFIXPLCE
| Q4 25 | -1.0% | -1.3% | ||
| Q3 25 | -11.1% | -1.8% | ||
| Q2 25 | -6.9% | -14.1% | ||
| Q1 25 | -27.4% | -2.0% | ||
| Q4 24 | -13.5% | 5.1% | ||
| Q3 24 | -13.9% | -10.0% | ||
| Q2 24 | -16.8% | -14.1% | ||
| Q1 24 | -19.1% | -28.3% |
每股收益（稀释后）OFIXPLCE
| Q4 25 | $-0.05 | $-0.19 | ||
| Q3 25 | $-0.57 | $-0.24 | ||
| Q2 25 | $-0.36 | $-1.57 | ||
| Q1 25 | $-1.35 | $-0.60 | ||
| Q4 24 | $-0.76 | $1.57 | ||
| Q3 24 | $-0.71 | $-2.51 | ||
| Q2 24 | $-0.88 | $-2.98 | ||
| Q1 24 | $-0.95 | $-10.24 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $82.0M | $7.3M |
| 总债务越低越好 | — | $107.4M |
| 股东权益账面价值 | $450.0M | $-8.6M |
| 总资产 | $850.6M | $762.5M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资OFIXPLCE
| Q4 25 | $82.0M | $7.3M | ||
| Q3 25 | $62.9M | $7.8M | ||
| Q2 25 | $65.6M | $5.7M | ||
| Q1 25 | $58.0M | $5.3M | ||
| Q4 24 | $83.2M | $5.7M | ||
| Q3 24 | $30.1M | $9.6M | ||
| Q2 24 | $26.4M | $13.0M | ||
| Q1 24 | $27.0M | $13.6M |
总债务OFIXPLCE
| Q4 25 | — | $107.4M | ||
| Q3 25 | $157.2M | $107.2M | ||
| Q2 25 | $157.0M | $107.0M | ||
| Q1 25 | $156.9M | $166.0M | ||
| Q4 24 | $157.0M | $165.7M | ||
| Q3 24 | $118.5M | $165.4M | ||
| Q2 24 | $118.0M | $166.6M | ||
| Q1 24 | $118.2M | $49.8M |
股东权益OFIXPLCE
| Q4 25 | $450.0M | $-8.6M | ||
| Q3 25 | $442.5M | $-4.9M | ||
| Q2 25 | $458.3M | $1.4M | ||
| Q1 25 | $458.3M | $-59.4M | ||
| Q4 24 | $503.1M | $-49.6M | ||
| Q3 24 | $525.9M | $-68.9M | ||
| Q2 24 | $546.0M | $-34.9M | ||
| Q1 24 | $570.3M | $-9.0M |
总资产OFIXPLCE
| Q4 25 | $850.6M | $762.5M | ||
| Q3 25 | $832.6M | $805.1M | ||
| Q2 25 | $837.2M | $779.6M | ||
| Q1 25 | $823.1M | $747.6M | ||
| Q4 24 | $893.3M | $888.8M | ||
| Q3 24 | $867.9M | $921.4M | ||
| Q2 24 | $882.0M | $848.3M | ||
| Q1 24 | $906.0M | $800.3M |
负债/权益比OFIXPLCE
| Q4 25 | — | — | ||
| Q3 25 | 0.36× | — | ||
| Q2 25 | 0.34× | 75.63× | ||
| Q1 25 | 0.34× | — | ||
| Q4 24 | 0.31× | — | ||
| Q3 24 | 0.23× | — | ||
| Q2 24 | 0.22× | — | ||
| Q1 24 | 0.21× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $27.7M | $6.2M |
| 自由现金流经营现金流 - 资本支出 | $16.8M | $-3.4M |
| 自由现金流率自由现金流/营收 | 7.6% | -1.0% |
| 资本支出强度资本支出/营收 | 4.9% | 2.8% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-1.3M | $39.5M |
8季度趋势，按日历期对齐
经营现金流OFIXPLCE
| Q4 25 | $27.7M | $6.2M | ||
| Q3 25 | $12.4M | $-30.5M | ||
| Q2 25 | $11.6M | $-43.0M | ||
| Q1 25 | $-18.4M | $121.3M | ||
| Q4 24 | $23.7M | $-44.2M | ||
| Q3 24 | $11.7M | $-83.9M | ||
| Q2 24 | $9.0M | $-110.8M | ||
| Q1 24 | $-18.6M | $135.4M |
自由现金流OFIXPLCE
| Q4 25 | $16.8M | $-3.4M | ||
| Q3 25 | $2.5M | $-31.9M | ||
| Q2 25 | $4.5M | $-46.4M | ||
| Q1 25 | $-25.1M | $121.2M | ||
| Q4 24 | $15.2M | $-47.7M | ||
| Q3 24 | $6.3M | $-91.7M | ||
| Q2 24 | $-360.0K | $-115.5M | ||
| Q1 24 | $-29.1M | $132.2M |
自由现金流率OFIXPLCE
| Q4 25 | 7.6% | -1.0% | ||
| Q3 25 | 1.2% | -10.7% | ||
| Q2 25 | 2.2% | -19.2% | ||
| Q1 25 | -13.0% | 29.7% | ||
| Q4 24 | 7.0% | -12.2% | ||
| Q3 24 | 3.2% | -28.7% | ||
| Q2 24 | -0.2% | -43.1% | ||
| Q1 24 | -15.4% | 29.1% |
资本支出强度OFIXPLCE
| Q4 25 | 4.9% | 2.8% | ||
| Q3 25 | 4.8% | 0.5% | ||
| Q2 25 | 3.5% | 1.4% | ||
| Q1 25 | 3.5% | 0.0% | ||
| Q4 24 | 4.0% | 0.9% | ||
| Q3 24 | 2.7% | 2.4% | ||
| Q2 24 | 4.7% | 1.8% | ||
| Q1 24 | 5.6% | 0.7% |
现金转化率OFIXPLCE
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -2.20× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
PLCE
| The Childrens Place US | $307.4M | 91% |
| The Childrens Place International | $32.1M | 9% |
| Gift Cards | $1.7M | 1% |
